11 aug: De bedste amerikanske karrierebyer
12 aug: Store, fristende landejendomme
11-08-2008 22:03:00

Nortech Systems Achieves ISO 13485 Quality Certification

Relateret indhold

Nortech Systems Incorporated (NASDAQ: NSYS) announced it has achieved

ISO 13485 quality certification for its electronics manufacturing

services (EMS) facilities in Merrifield and Baxter, Minn. This

certification allows Nortech to further demonstrate its ability to

provide products and related services to the medical industry that

consistently meet customer and regulatory requirements.

"The medical market continues to show strong growth and we believe this

new ISO certification positions us to capitalize on additional

business," said Mike Degen, president and CEO of Nortech Systems. The

market research firm Technology Forecasters expects medical

opportunities for EMS companies like Nortech to increase 17 percent

annually through 2010, the fastest growth of any market sector.

According to Degen, Nortech Systems has already been proudly assisting

numerous medical OEMs with the production of their non-invasive

equipment, including potentially life-sustaining devices. "This

certification validates and reinforces the critical supporting role

we´ve been playing for our customers all along," he commented.

Based on the ISO 9001 international quality standard, ISO 13485 includes

additional analysis of risk, safety and regulatory requirements. It also

corresponds to a comparable standard of the U.S. Food & Drug

Administration. All Nortech facilities are certified to ISO 9001:2001

standards and the company also employs an enterprise-wide lean

manufacturing initiative utilizing tools such as kaizen, Six Sigma,

rapid action, Balanced Scorecard and 5S.

Fortune Small Business magazine recently ranked Nortech Systems on its

list of "America´s 100 Fastest-Growing Small Public Companies."

About Nortech Systems, Incorporated

Nortech Systems Incorporated (www.nortechsys.com),

based in Wayzata, Minn., is a full-service electronics manufacturing

services (EMS) provider of wire and cable assemblies, printed circuit

board assemblies, and higher-level complete box build assemblies for a

wide range of industries. Markets served include industrial equipment,

military/defense, medical and transportation.

The company has manufacturing capabilities and operating partners in the

U.S., Asia and Latin America. Nortech Systems Incorporated is traded on

the NASDAQ Stock Market under the symbol NSYS.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to

the safe harbor provision of the Private Securities Litigation Reform

Act of 1995. While this release is based on managements

best judgment and current expectations, actual results may differ and

involve a number of risks and uncertainties. Important factors that

could cause actual results to differ materially from the forward-looking

statements include, without limitation: volatility in market conditions

which may affect market supply of and demand for the companys

products; increased competition; changes in the reliability and

efficiency of operating facilities or those of third parties; risks

related to availability of labor; commodity and energy cost instability;

general economic, financial and business conditions that could affect

the companys financial condition and results

of operations; as well as risk factors listed from time to time in the

companys filings with the SEC.

Brookside Communications Group

Warren Djerf, 952-920-3908

warren@brookcomm.net

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Novo: EMA-udvalg anbefaler markedsføringstilladelse til Refixia - NY

24-03-2017 13:31:36
Udvalget for humanmedicinske lægemidler (CHMP) ved Det Europæiske Lægemiddelsagentur (EMA) har tildelt Novo Nordisks Refixia en positiv udtalelse og anbefaler en markedsføringstilladelse.Det skriver Novo Nordisk i en fondsbørsmeddelelse.CHMP anbefaler en markedsføringstilladelse til Refixia til unge og voksne med hæmofili B. Til grund for anbefalingen ligger resultater fra udviklingsprogrammet par..

Novo/Exane: Kursmålet skæres til 270 kr.

24-03-2017 10:17:22
Den franske storbank Exane BNP Paribas skærer kursmålet for aktien i Novo Nordisk til 270 kr. fra 295 kr. Anbefalingen er uændret "outperform", viser data fra Bloomberg.Novo-aktien falder fredag 0,4 pct., eller 1 kr., til 233,20 kr. Det dækker dog over en stigning, da aktien ikke længere handles inklusive retten til et udbytte på 4,60 kr./ritzau/FINANSJakob Dalskov +45 33 30 03 35 Ritzau Finans, E..

Aktier/tendens: Mulighed for mere gas til Mærsk i ventet rødt C20

24-03-2017 08:31:54
Det danske aktiemarked kan fredag blive præget af små udsving med en lille overvægt af negative fortegn.A.P. Møller-Mærsks B-aktie var uændret efter torsdagens handel og blev handlet til 11.500 kr. Aktien kan dog gå fra grå til grøn fredag, da der er potentielt gode nyheder til det danske konglomerat.Efter en Nordsø-aftale, der kan redde det ellers lukningstruede Tyra-felt, skriver Jyllands-Posten..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Nordea har fældet hemmelig dom over PostNords kvaler
2
Fredagens aktier: C20 Cap i slutspurt mens Dong steg til vejrs
3
Aktier/Sydbank: Forventningerne til C25 Cap-indekset løftes
4
Trumps sundhedsreform rykker nærmere afstemning
5
USA: Finansminister snart klar med forslag til skattereform

Relaterede aktiekurser

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
25. marts 2017 14:39:27
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20170324.2 - EUROWEB3 - 2017-03-25 14:39:27 - 2017-03-25 14:39:27 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x